• Andrey D. Volgin
  • Alim Bashirzade
  • Tamara G. Amstislavskaya
  • Oleg A. Yakovlev
  • Konstantin A. Demin
  • Ying Jui Ho
  • Dongmei Wang
  • Vadim A. Shevyrin
  • Dongni Yan
  • Zhichong Tang
  • Jingtao Wang
  • Mengyao Wang
  • Erik T. Alpyshov
  • Nazar Serikuly
  • Edina A. Wappler-Guzzetta
  • Anton M. Lakstygal
  • Allan V. Kalueff

Arecoline is a naturally occurring psychoactive alkaloid from areca (betel) nuts of the areca palm (Areca catechu) endemic to South and Southeast Asia. A partial agonist of nicotinic and muscarinic acetylcholine receptors, arecoline evokes multiple effects on the central nervous system (CNS), including stimulation, alertness, elation, and anxiolysis. Like nicotine, arecoline also evokes addiction and withdrawal symptoms (upon discontinuation). The abuse of areca nuts is widespread, with over 600 million users globally. The importance of arecoline is further supported by its being the world's fourth most commonly used human psychoactive substance (after alcohol, nicotine, and caffeine). Here, we discuss neuropharmacology, pharmacokinetics, and metabolism of arecoline, as well as social and historical aspects of its use and abuse. Paralleling clinical findings, we also evaluate its effects in animal models and outline future clinical and preclinical CNS research in this field.

Original languageEnglish
Pages (from-to)2176-2185
Number of pages19
JournalACS Chemical Neuroscience
Volume10
Issue number5
DOIs
StatePublished - 15 May 2019

    Research areas

  • alkaloid, animal models, Arecoline, clinical effects, nicotine-like action, ZEBRAFISH, RAT, DRUG DISCOVERY, MOUSE, ARECA NUT USE, PREVALENCE, BETEL QUID CARCINOGENESIS, N-OXIDE, PHARMACOLOGY, STRESS

    Scopus subject areas

  • Cognitive Neuroscience
  • Biochemistry
  • Physiology
  • Cell Biology

ID: 47608216